Background Increased pigmentation has been associated with cancer stem-cell-like behaviour and chemoresistance in uveal ...

Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

An aggressive form of cancer could be detected earlier through a simple breath test being developed by researchers from ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Small cell lung cancer (SCLC) is one of the hardest types of cancer to treat and has often already spread by the time people are diagnosed. It mainly arises from neuroendocrine (NE) cells, which help ...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner.

Researchers have identified the transfer of mitochondria with mutated DNA from cancer cells to immune cells as a key ...

Cancer cells cripple immune cells by donating their damaged mitochondria, hindering the immune response and fostering tumour ...

The tumours in these mice showed high expression of cancer stem cell markers CD56 and CD20, suggesting a role for mutant vimentin in driving cancer stem cell-like behaviour that is often ...

New research has found that changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth.